WOBBLER MICE MODELING MOTOR NEURON DISEASE DISPLAY ELEVATED TRANSACTIVE RESPONSE DNA BINDING PROTEIN
被引:46
作者:
Dennis, J. S.
论文数: 0引用数: 0
h-index: 0
机构:
Bay Pines VA Healthcare Syst, Mol Biol Lab, Bay Pines, FL 33744 USABay Pines VA Healthcare Syst, Mol Biol Lab, Bay Pines, FL 33744 USA
Dennis, J. S.
[1
]
Citron, B. A.
论文数: 0引用数: 0
h-index: 0
机构:
Bay Pines VA Healthcare Syst, Mol Biol Lab, Bay Pines, FL 33744 USA
Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA
Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USABay Pines VA Healthcare Syst, Mol Biol Lab, Bay Pines, FL 33744 USA
Citron, B. A.
[1
,2
,3
]
机构:
[1] Bay Pines VA Healthcare Syst, Mol Biol Lab, Bay Pines, FL 33744 USA
[2] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
Wobbler mice model motor neuron disease with a substantial decline in motor neurons. TDP-43 is a nucleic acid binding protein that accumulates, along with ubiquitin, in the cytoplasm of amyotrophic lateral sclerosis (ALS) motor neurons. Recently, it was reported that Cu/Zn superoxide dismutase type 1 (SOD1) familial amyotrophic lateral sclerosis (fALS) model mice do not mimic the TDP-43 changes seen in sporadic ALS, although they share a large number of other properties with the human disorder. We examined ubiquitin inclusions and TDP-43 expression in wobbler mice. TDP-43 mRNA, measured by quantitative reverse transcription-coupled PCR, was elevated in the wobbler spinal cord. Immuno-histochernistry revealed intracellular ubiquitin inclusions and abnormal distribution of TDP-43 into the cytoplasm in wobblers similar to the staining reported in ALS. Finally, nuclear and cytoplasmic fractions, examined by Western immunoblotting, confirmed a delocalization of TDP-43 in the neurodegenerative wobbler. These observations indicate that wobbler mice, which suffer motor neuron loss at 21 days, undergo TDP-43 and ubiquitin changes characteristic of sporadic ALS. Published by Elsevier Ltd on behalf of IBRO.